Published August, 2014
By Nicholas J. Brandon, Anthony R. West and NJ Brandon
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

This book reviews advances in understanding phosphodiesterases within the central nervous system and their therapeutic applications. A range of expert authors from both academia and industry describe these, then focus on the areas of greatest scientific and medical interest to provide more detailed coverage.

---

Published October, 2011
By Binghe Wang, Nouri Neamati and N Neamati
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery.

---

Published August, 2011
By Xiaoling Li, Ming Hu and M Hu
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

Understanding bioavailability is critical to determining the amount of a drug to administer.

---

Published January, 2010
By Binghe Wang, Chao Han, Charles B. Davis and C Han
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

Explaining the assessment of potential drug compounds, this is an ideal introductory reference for those new to drug discovery. It includes sections on pharmacokinetics and drug metabolism, integration of pharmaceutical development, and predictive safety assessment.

---

Published November, 2009
By Rongshi Li, Jeffrey A. Stafford and R Li
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

Kinase Inhibitor Drugs covers a wide and comprehensive range of topics about kinase-targeted inhibitors in cancer therapy, one of the hottest drug targets in modern drug discovery.

---

Published September, 2009
By Binghe Wang, Claudiu T. Supuran, Jean-Yves Winum, Jean–Yves Winum and CT Supuran
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

The book gives students and young researchers a resource on zinc enzymes, some of which were intensively studied for more than six decades and translated into model success stories of the pharmaceutical industry.

---

Published August, 2008
By Binghe Wang, Mark L. Trudell, Sari Izenwasser and ML Trudell
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

Both a reference source for researchers and a text for graduate students investigating the various aspects of the dopamine transporter (DAT), Dopamine Transporter: Chemistry, Biology, and Pharmacology includes aspects of chemistry, biology, and pharmacology and provides a strong general overview of this neurotransmitter.

---

Published December, 2007
By Binghe Wang, Albert P. Li and AP Li
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market.

---

Published July, 2006
By Sean Ekins, Binghe Wang and S Ekins
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Series: Wiley Series in Drug Discovery and Development
Rating:
Availability: Available

Computer Applications in Pharmaceutical Research and Development analyzes the use of computers through the entire pharmaceutical process of discovering, developing, and marketing new medicines.

---